Index Partners Llcyook Paul... Net Worth

The estimated Net Worth of Index Partners Llcyook Paul... is at least $15.6 Million dollars as of 30 April 2019. Index Paul owns over 200 units of Novus Therapeutics Inc stock worth over $15,561,658 and over the last 6 years Index sold NVUS stock worth over $540.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Index Paul NVUS stock SEC Form 4 insiders trading

Index has made over 1 trades of the Novus Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Index sold 200 units of NVUS stock worth $540 on 30 April 2019.

The largest trade Index's ever made was selling 200 units of Novus Therapeutics Inc stock on 30 April 2019 worth over $540. On average, Index trades about 200 units every 0 days since 2019. As of 30 April 2019 Index still owns at least 1,065,867 units of Novus Therapeutics Inc stock.

You can see the complete history of Index Paul stock trades at the bottom of the page.

Insiders trading at Novus Therapeutics Inc

Over the last 8 years, insiders at Novus Therapeutics Inc have traded over $2,287,089 worth of Novus Therapeutics Inc stock and bought 1,499,013 units worth $7,312,148 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Israel Gp Ltd.Orbi Med Isra..., and Erez Chimovits. On average, Novus Therapeutics Inc executives and independent directors trade stock every 100 days with the average trade being worth of $1,832,709. The most recent stock trade was executed by Israel Gp Ltd.Orbi Med Isra... on 2 December 2020, trading 103,200 units of NVUS stock currently worth $2,229,120.

What does Novus Therapeutics Inc do?

Complete history of Index Paul stock trades at Novus Therapeutics Inc

Novus Therapeutics Inc executives and stock owners

Novus Therapeutics Inc executives and other stock owners filed with the SEC include:

• John McBride,
  Director
• Jon Kuwahara,
  Chief Financial Officer, Chief Accounting Officer
• Keith Katkin,
  Independent Chairman of the Board
• Walter Ogier,
  Independent Director
• David-Alexandre Gros,
  Chief Executive Officer, Director
• Steven Perrin,
  President, Chief Scientific Officer
• Gary Lyons,
  Independent Director
• Christine Ocampo,
  See Remarks
• Israel Gp Ltd.Orbi Med Isra...,
  
• Cheryl Cohen,
  Director
• Jodie Pope Morrison,
  Director
• Erez Chimovits,
  Director
• Index Partners Llcyook Paul...,
  
• Gregory J. Flesher,
  Chief Executive Officer
• Catherine C. Turkel,
  President
• Global Management Lp Logos,
  10% owner
• Partners L P/Ilbiotechnolog...,